New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Two of the fastest growing areas involving the use of robotics are in medicine and in liquid and material handling applications in biotechnology. Robotic systems have already found their way into a number of other industries as well. In a recent interview with Quartz magazine, Bill Gates argues that since humans are losing their jobs to robots governments should “tax companies’ use of them [robots] as a way to at least temporarily slow the spread of automation and to fund other types of employment.”